Evidence map›Paper›PMID 40516949›Full record

ArticleSaudi medical journal2025

Patterns of dermatological emergencies at a tertiary hospital in Southwestern Saudi Arabia: A descriptive study.

Hamad A Alfahaad

Abstract read
In one paragraph

Article in Saudi medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Hamad A AlfahaadFrom the College of Medicine, Najran University, Kingdom of Saudi Arabia.ORCID https://orcid.org/0000-0002-3873-1728

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo examine the patterns and characteristics of dermatological emergencies managed at a tertiary hospital in the Southwest Region of Saudi Arabia.

methodsThis study employed a retrospective cross-sectional design conducted at King Khalid Hospital in Najran, Saudi Arabia. The study included patients who either visited the dermatology or emergency departments or were hospitalized due to dermatological conditions treated between January 2019 and December 2024.

resultsThe study included 126 patients, with an almost equal distribution of males (50.8%) and females (49.2%), predominantly Saudi nationals (78.6%). Most patients were aged 18-60 (65.1%) years. The most common skin lesion was vesiculobullous (23.3%), and infectious diseases (42%) were the leading diagnoses. Lesions were mainly generalized (43.7%). Outcomes showed 31% full recovery, 59% recovery with complications, and 10% mortality. Complications included hepatitis (24%) and hyperpigmentation/hypopigmentation (23%). Most patients (77%) had no co-morbidities. All received supportive treatments, with 88.9% given systemic therapies, predominantly systemic steroids (42%).

conclusionThis study highlights the diverse spectrum of dermatological emergencies at a tertiary hospital in Southwest Saudi Arabia, emphasizing the predominance of infectious diseases and significant complications faced by patients. The findings underscore the need for comprehensive management strategies and prompt interventions to improve patient outcomes. Enhanced understanding of demographic factors, common diagnoses, and treatment patterns can guide future healthcare policies and resource sallocation.

Indexed as

EmergenciesSkin DiseasesTertiary Care CentersAdolescentAdultAgedChildCross-Sectional StudiesEmergency Service, HospitalFemaleHumansMaleMiddle AgedRetrospective StudiesSaudi ArabiaYoung Adultdermatological emergenciesdrug reactiontoxic epidermal necrolysisviral exanthem

Identifiers

PMID40516949
PMCPMC12199650

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.